Jump to content


Renata Rothbarth

Required field
Required field
Required field
Required field

Required field
Required field
Required field

(*) Required fields

Machado Meyer respects your privacy and uses personal data only for your request.
If you wish to see with subjects that may be of interest to you, select below:

Please select at least one option

I agree with to receive communications from Machado Meyer.

You may unsubscribe from us at any time. To learn more, see our Privacy Policy.

By clicking send, you agree to allow Machado Meyer to store and process the personal data filled in above.

Renata Rothbarth

Since 2013, Renata has been assisting investors, leading and emerging companies in a wide range of contractual and regulatory issues relating to pharmaceuticals, biotechnology, vaccines, medical devices, and other health-regulated products. She also specializes in health innovation, clinical research, medical cannabis, advanced therapies such as genetic therapies, health insurance, drug pricing, public health, and public-private partnerships.

Her expertise lies in negotiating contracts that involve complex regulatory, business, and operational issues. This includes strategic alliances, research and development collaborations, technology licenses and acquisitions, productive development partnerships, pre-commercial procurement/technological orders, risk-sharing agreements, health data-driven transactions, manufacturing and distribution of regulated products, outsourcing, and clinical research.

In particular, Renata has developed extensive expertise in structuring innovative and complex payment/business models involving telemedicine, strategies for incorporating technologies into public and private healthcare systems, big data and analytics, artificial intelligence, virtual trials, genetics, precision medicine, wearable technologies, bioprinting, software as a medical device (SaMD), electronic health records (EHR), Internet of Medical Things (IoMT), medical discount and patient programs and health data privacy.

In addition to providing legal advice on mapping opportunities for engagement with federal, state or municipal entities and associations, Renata advises clients' business and legal teams on day-to-day issues. She actively works on the regulatory structuring of mergers and acquisitions or joint ventures involving pharmaceutical and medical device companies, health plan operators, for-profit and non-profit health service providers, healthtechs and others.

Renata also holds extensive experience with administrative and in-court proceedings involving Brazilian health authorities such as the National Sanitary Surveillance Agency (ANVISA), National Health Insurance Agency (ANS), Ministry of Health (MS) and the National Commission for Incorporation of Health Technologies (CONITEC).

Recent acknowledgments

  • Chambers & Partners Latin America: Life Sciences and Healthcare - Regulatory (2020-2023)
    • The Legal 500: ranked as “Rising Star” of the Life Sciences industry (2020-2023); Life Sciences, ranked as "Next Generation Partners" (2024)
    • Análise Advocacia: Regulatory, mentioned among the most admired female lawyers (2023/2024)


  • University of São Paulo (USP) – Doctor of Philosophy (PhD), in progress
  • University of São Paulo (USP) – Master of Sciences, 2018
  • Sherwin B. Nuland Institute in Bioethics/Yale University (United States) – Extension course in Health Law and Bioethics, 2017
  • Faculdade de Direito de Curitiba (FDC) – Bachelor of Laws, 2013

Other qualifications

    • Author and co-author of several scientific publications, she frequently lectures on life sciences and digital health topics in industry and academic settings
  • Assistant researcher at the Centro de Estudos e Pesquisas em Direito Sanitário (Cepedisa/USP)
  • Guest specialist invited to define the Ministry of Health’s National Digital Health Strategy for 2020-2028


  • Brazilian Association of Health Startups
  • International Bar Association
  • Brazilian Bar Association
Logo Machado Meyer